Answer to Question 1
Correct Answer: 4
Rationale 1: The medications will not help to restore balance between serotonin and acetylcholine.
Rationale 2: Medications do not prevent muscle wasting.
Rationale 3: Medications do not boost energy or appetite.
Rationale 4: The goal of pharmacotherapy for Parkinson disease is to increase an individual's ability to perform activities of daily living, such as walking, dressing, eating, and bathing.
Global Rationale: The goal of pharmacotherapy for Parkinson disease is to increase an individual's ability to perform activities of daily living, such as walking, dressing, eating, and bathing. The medications will not help to restore balance between serotonin and acetylcholine; prevent muscle wasting; or boost energy or appetite.
Answer to Question 2
Correct Answer: 2,3,4,5
Rationale 1: Glutamatergic inhibitors are not the most common class of drugs for treating Alzheimer disease.
Rationale 2: Depression and aggressive behavior are common symptoms of the disease.
Rationale 3: Memory difficulties are an early symptom of Alzheimer disease.
Rationale 4: It is suspected that chronic inflammation and excess free radicals can cause neuron damage and contribute to the disease.
Rationale 5: The acetylcholinesteras e inhibitors are the most widely used class of drugs for treating the disease. These drugs work by increasing the availability of acetylcholine. Acetylcholine is involved in cognition, memory, and learning.
Global Rationale: Depression and aggressive behavior are common symptoms of the Alzheimer disease. Memory difficulties are an early symptom of Alzheimer disease. It is suspected that chronic inflammation and excess free radicals can cause neuron damage and contribute to the disease. The acetylcholinesteras e inhibitors are the most widely used class of drugs for treating the disease. These drugs work by increasing the availability of acetylcholine. Acetylcholine is involved in cognition, memory, and learning. Glutamatergic inhibitors are not the most common class of drugs for treating Alzheimer disease.